Clinical Trials Logo

Ureter Carcinoma clinical trials

View clinical trials related to Ureter Carcinoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT05059444 Recruiting - Clinical trials for Non-small Cell Lung Cancer

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ORACLE
Start date: September 7, 2021
Phase:
Study type: Observational

The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and explore its value in a healthcare environment subject to cost containment.

NCT ID: NCT03397394 Terminated - Bladder Cancer Clinical Trials

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

ATLAS
Start date: June 1, 2018
Phase: Phase 2
Study type: Interventional

The purpose of the ATLAS study is to determine how patients with locally advanced unresectable or metastatic urothelial carcinoma respond to treatment with rucaparib.